Home > > > > Report Detail

Global Cardiac Biomarkers Market 2022-2028

Publisher Name :
Date: 05-Jul-2022
No. of pages: 80

Cardiac biomarkers are of great importance in the timely, accurate diagnosis and management of acute coronary syndrome as well as the prognosis. Diagnosis in the golden period is of utmost importance to institute therapy at the earliest and possibly reverse the myocardial damage. Cardiac biomarkers are also a powerful tool for triaging. The global cardiac biomarkers market is expected to increase by USD 7 billion, at a compound annual growth rate (CAGR) of 9.3% from 2022 to 2028, according to the latest edition of the Global Cardiac Biomarkers Market Report.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global cardiac biomarkers market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the cardiac biomarkers industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, location of testing, application, and region. The global market for cardiac biomarkers can be segmented by type: albumin, creatine kinase-MB (CK-MB), low-density lipoproteins (LDL) and high-density lipoproteins (HDL), myoglobin, natriuretic peptides - B-type natriuretic peptide (BNP) & N-terminal pro b-type natriuretic peptide (NT-proBNP), troponins, others. Cardiac biomarkers market is further segmented by location of testing: laboratory testing, point of care testing. Based on application, the cardiac biomarkers market is segmented into: acute coronary syndrome, atherosclerosis, congestive heart failure, myocardial infarction, others. On the basis of region, the cardiac biomarkers market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By type:

- albumin

- creatine kinase-MB (CK-MB)

- low-density lipoproteins (LDL) and high-density lipoproteins (HDL)

- myoglobin

- natriuretic peptides - B-type natriuretic peptide (BNP) & N-terminal pro b-type natriuretic peptide (NT-proBNP)

- troponins

- others

By location of testing:

- laboratory testing

- point of care testing

By application:

- acute coronary syndrome

- atherosclerosis

- congestive heart failure

- myocardial infarction

- others

By region:

- North America

- Asia Pacific

- Europe

- Rest of the World (ROW)

The report also provides a detailed analysis of several leading cardiac biomarkers market vendors that include Abbott Laboratories, ACS Biomarker B.V., bioMerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis AG, QuidelOrtho Corporation, Randox Laboratories Ltd., Siemens AG, Thermo Fisher Scientific Inc., Tosoh Bioscience, Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

- To analyze and forecast the market size of the global cardiac biomarkers market.

- To classify and forecast the global cardiac biomarkers market based on type, location of testing, application, region.

- To identify drivers and challenges for the global cardiac biomarkers market.

- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global cardiac biomarkers market.

- To identify and analyze the profile of leading players operating in the global cardiac biomarkers market.

Why Choose This Report

- Gain a reliable outlook of the global cardiac biomarkers market forecasts from 2022 to 2028 across scenarios.

- Identify growth segments for investment.

- Stay ahead of competitors through company profiles and market data.

- The market estimate for ease of analysis across scenarios in Excel format.

- Strategy consulting and research support for three months.

- Print authentication provided for the single-user license.

Global Cardiac Biomarkers Market 2022-2028

Table of Contents

FIGURES AND TABLES

PART 1. INTRODUCTION
* Report description
* Objectives of the study
* Market segment
* Years considered for the report
* Currency
* Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW
* Introduction
* Drivers
* Restraints
* Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY TYPE
* Albumin
* Creatine kinase-MB (CK-MB)
* Low-density lipoproteins (LDL) and high-density lipoproteins (HDL)
* Myoglobin
* Natriuretic peptides - B-type natriuretic peptide (BNP) & N-terminal pro b-type natriuretic peptide (NT-proBNP)
* Troponins
* Others

PART 6. MARKET BREAKDOWN BY LOCATION OF TESTING
* Laboratory testing
* Point of care testing

PART 7. MARKET BREAKDOWN BY APPLICATION
* Acute coronary syndrome
* Atherosclerosis
* Congestive heart failure
* Myocardial infarction
* Others

PART 8. MARKET BREAKDOWN BY REGION
* North America
* Asia Pacific
* Europe
* Rest of the World (ROW)

PART 9. KEY COMPANIES
* Abbott Laboratories
* ACS Biomarker B.V.
* bioMerieux SA
* Bio-Rad Laboratories, Inc.
* Danaher Corporation
* F. Hoffmann-La Roche AG
* Johnson & Johnson
* Novartis AG
* QuidelOrtho Corporation
* Randox Laboratories Ltd.
* Siemens AG
* Thermo Fisher Scientific Inc.
* Tosoh Bioscience, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
  • Global Biomarkers Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biomarkers market size was valued at US$ 61570 million in 2023. With growing demand in downstream market, the Biomarkers is forecast to a readjusted size of US$ 165240 million by 2030 with a CAGR of 15.1% during review period. The research report highlights the growth potential of the global Biomarkers market. Biomarkers are expected to show stable growth in the future market. However, product differentiation, reducing costs,......
  • Global Biomarker (Medicine) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Biomarker (Medicine) market: According to our latest research, the global Biomarker (Medicine) market looks promising in the next 5 years. As of 2022, the global Biomarker (Medicine) market was estimated at USD 54332.95 million, and it's anticipated to reach USD 82760.29 million in 2028, with a CAGR of 7.27% during the forecast years. Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker i......
  • Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size was valued at US$ 20920 million in 2023. With growing demand in downstream market, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications is forecast to a readjusted size of US$ 29400 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Commercializing Biom......
  • Global Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Biomarkers market: According to our latest research, the global Biomarkers market looks promising in the next 5 years. As of 2022, the global Biomarkers market was estimated at USD 76755.97 million, and it's anticipated to reach USD 184776.75 million in 2028, with a CAGR of 15.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biomarkers market, with a......
  • Global Biomarker Technology Market Research Report 2023
    Published: 01-Dec-2023        Price: US 2900 Onwards        Pages: 86
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biomarker Technology market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - Quanterix - Bio-Rad Laboratories - Epigenomics - Agilent Technologies - Johnson & Johnson - Qiagen - Roche Ho......
  • Global Renal Biomarkers Market Research Report 2023
    Published: 01-Dec-2023        Price: US 2900 Onwards        Pages: 99
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Renal Biomarkers market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Diagnostics - F. Hoffmann-La Roche - Beckman Coulter - Siemens Healthcare Diagnostics - Thermo Fisher Scientific - Astute Medical - Bio......
  • Global Central Nervous System (CNS) Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Central Nervous System (CNS) Biomarkers market: According to our latest research, the global Central Nervous System (CNS) Biomarkers market looks promising in the next 5 years. As of 2022, the global Central Nervous System (CNS) Biomarkers market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. An overview of the global market for central nervous system (CNS) biomarke......
  • Global Cancer Biomarker Market Research Report 2023
    Published: 13-Nov-2023        Price: US 2900 Onwards        Pages: 109
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cancer Biomarker market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Thermo Fisher Scientific - Bio-Rad Laboratories - Roche Diagnostics - Qiagen - Illumina - GE Healthcare - Agilent Technologies - Biomér......
  • Biomarker Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300
    Biomarker Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the biomarker deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of biomarker deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter biomarker deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercializ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs